Latest Articles
Prime members get early access tickets to 'Spider-Man: Brand New Day' - Mashable
Prime members get early access tickets to 'Spider-Man: Brand New Day' Mashable
Published: June 3, 2026, 2:37 p.m.
Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle - HarianBasis.co
Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle HarianBasis.co
Published: June 3, 2026, 2:31 p.m.
Scientific Meeting of the IVF Unit "Institute of Life - IASO" - Iaso
Scientific Meeting of the IVF Unit "Institute of Life - IASO" Iaso
Published: June 3, 2026, 12:40 p.m.
BBC presenter ‘can’t remember single thing’ about broadcast due to ‘horrific’ pain - The Independent
BBC presenter ‘can’t remember single thing’ about broadcast due to ‘horrific’ pain The Independent
Published: June 3, 2026, 9:39 a.m.
Robert and Terri Irwin Share Update on Bindi's Health as They Explain Her Absence from Gala Honoring Late Dad Steve - AOL.com
Robert and Terri Irwin Share Update on Bindi's Health as They Explain Her Absence from Gala Honoring Late Dad Steve AOL.com
Published: June 3, 2026, 9:17 a.m.
Ibuprofen and endometrial cancer: An observational study finds a positive association. - unicaradio.it
Ibuprofen and endometrial cancer: An observational study finds a positive association. unicaradio.it
Published: June 3, 2026, 8:48 a.m.
"Endometriosis is a thief." Emma Barnett on the disease stealing women's lives - The Female Lead
"Endometriosis is a thief." Emma Barnett on the disease stealing women's lives The Female Lead
Published: June 3, 2026, 8:20 a.m.
Helping Doctors Diagnose Endometriosis Faster with AI - Ontario's Universities
Helping Doctors Diagnose Endometriosis Faster with AI Ontario's Universities
Published: June 3, 2026, 8:04 a.m.
Her Voice Project co-founder leaves HSE taskforce over concerns of delivering changes for endometriosis patients - MSN
Her Voice Project co-founder leaves HSE taskforce over concerns of delivering changes for endometriosis patients MSN
Published: June 3, 2026, 6:19 a.m.
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer - Oncodaily
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer Oncodaily
Published: June 3, 2026, 3:15 a.m.
Link copied to clipboard!